In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats.
about
The blood-brain barrier: bottleneck in brain drug developmentA single siRNA suppresses fatal encephalitis induced by two different flaviviruses.Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrierA shift from cell cultures to creatures: in vivo imaging of small animals in experimental regenerative medicine.Intracranial administration of P gene siRNA protects mice from lethal Chandipura virus encephalitis.RNA interference and nonviral targeted gene therapy of experimental brain cancerTargeted disruption of outer limiting membrane junctional proteins (Crb1 and ZO-1) increases integration of transplanted photoreceptor precursors into the adult wild-type and degenerating retina.Tumor-targeted RNA-interference: functional non-viral nanovectors.The Trojan Horse Liposome Technology for Nonviral Gene Transfer across the Blood-Brain BarrierIntravenous, non-viral RNAi gene therapy of brain cancer.MicroRNA and brain tumors: a cause and a cure?Dissecting role of regulatory factors in NF-kappaB pathway with siRNA.The therapeutic potential of RNA interference.On the delivery of small interfering RNAs into mammalian cells.Knocking down transport: applications of RNA interference in the study of drug transport proteins.Silencing neurodegenerative disease: bringing RNA interference to the clinic.RNAi based approaches to the treatment of malignant glioma.RNA interference in pain research.Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies.shRNA and siRNA delivery to the brainTargeting potassium channels for increasing delivery of imaging agents and therapeutics to brain tumors.Specifically targeted gene therapy for small-cell lung cancer.Delivery of small-interfering RNA (siRNA) to the brain.Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier.The miRNA pathway in neurological and skeletal muscle disease: implications for pathogenesis and therapy.RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies.Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS.Lentiviral vector mediated delivery of RHBDD1 shRNA down regulated the proliferation of human glioblastoma cells.Selective gene silencing of rat ATP-binding cassette G2 transporter in an in vitro blood-brain barrier model by short interfering RNA.A simple protocol for preparation of a liposomal vesicle with encapsulated plasmid DNA that mediate high accumulation and reporter gene activity in tumor tissue.Effects of AAV-mediated knockdown of nNOS and GPx-1 gene expression in rat hippocampus after traumatic brain injury.Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery.Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles.Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS
P2860
Q22336985-F617D41A-EB7B-4028-8FAC-D61535E1984CQ25255046-28DE84E5-8B62-4AE4-A685-C064F7D66963Q26778701-18F93028-7441-4D7A-AF42-9BE98D1804E4Q28071873-CF4F6828-CF86-47C1-9B31-367B46F8DA3DQ30461932-7CAEE99A-C0E9-49B7-8DD9-43908D769FC2Q33523028-01F6714B-1B77-436A-A984-AC553A379BCBQ33569727-9C2EFD59-43D6-4306-A37E-349561535403Q34124455-B4DF65EA-6AF5-4AA5-80AA-A6DF8BF80732Q34974957-E2A18A2A-5624-4591-A584-14DE90E56068Q35585191-BF141112-2855-4629-BD67-5A3F4FE29C03Q35842672-43530398-C1D0-46D4-967A-4F6B35D9D8DEQ36065652-5C9826C6-1DB8-46C3-BF45-26E253186ECEQ36165374-A01BB0AF-278C-493F-A526-1FEBEF0EDDBAQ36237868-A2EC74F4-C5FC-4AA3-A0AF-9357DDBB1A3CQ36316859-6A9FE6C2-F3A2-40B6-BB6F-8561937677B9Q36360814-B2151C86-6FA7-4712-8FDA-385C9BC2A6A4Q36390831-D1692476-32A4-4786-895A-26AC0AB872BEQ36478665-B9B95C18-1BC4-40FC-A751-6A39247A0E34Q36618289-CEAE62B5-0899-4667-BCF3-1F870646366FQ36752048-8554ECE2-9D55-489C-9249-55B5705F57D9Q36791813-C6E3F86F-E213-4562-92BA-27790DC462D1Q36881899-CC6846BC-CAF2-4A07-AC03-5A1B83850860Q37449030-CD2793C8-864D-45A5-9ECD-A468A1F54B34Q37481282-01AF97E3-30CF-4084-A725-8F13F8431EDCQ37855817-B95DEAF5-68C3-48F2-8B15-6B753A8978BFQ37900519-01497FE0-9D8B-4217-B7AC-F43A322806B5Q38541950-1889C6EE-F8D6-4C94-AEB9-0F64A6001C2DQ38687781-443AE4F4-D95D-41C8-8CB7-D638E8A3DF38Q39120825-19F95487-023B-4AF7-9618-C5D229CCAC00Q40445681-5C1899F2-48A8-44D4-8471-4248E0EF293BQ41839754-447EA340-B7F1-429A-8FD1-B9B97F542DF8Q41920871-6B038866-995F-4012-B224-412CEEEBCB2FQ45880001-8E1CFE66-36D5-4CF1-AC60-60039D0B3705Q55400819-D18598FA-801B-4F09-980B-0E8DDE173814Q57675694-3152D0EA-1E78-482E-A705-AF27FE1F22CF
P2860
In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats.
@en
In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats.
@nl
type
label
In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats.
@en
In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats.
@nl
prefLabel
In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats.
@en
In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats.
@nl
P356
P1476
In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats.
@en
P2093
P304
P356
10.1002/JGM.449
P577
2003-12-01T00:00:00Z